MedTrace Logo

Anal Injury Screening for High Risk HPV

NCT04512508 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2020-08-13

No results posted yet for this study

Summary

The diagnosis of anal cancer is superior with the Anal Test system compared to liquid cytology and anoscopy.

Conditions

Interventions

DIAGNOSTIC_TEST

Self test sample

Self test sample, DNA analysis, Biopsy and Anoscopy

Sponsors & Collaborators

  • Hospital General de México Dr. Eduardo Liceaga

    lead OTHER_GOV

Principal Investigators

  • Luis G Molina Fernández de Lara · Hospital General de México Eduardo Liceaga

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-30
Primary Completion
2020-09-30
Completion
2021-01-31

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04512508 on ClinicalTrials.gov